ARTELO BIOSCIENCES, INC. Amortization of Debt Discount (Premium)
ARTELO BIOSCIENCES, INC. (ARTL) reported Amortization of Debt Discount (Premium) of $146 for the 6-month period ending 2018-02-28, per its 10-Q filed 2018-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2018-11-29
- ARTELO BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2017-08-31 was $279.00.
- ARTELO BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2017-05-31 was $152.00.
- ARTELO BIOSCIENCES, INC. amortization of debt discount (premium) for fiscal 2017 was $600.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2018-02-28 | $146.00 10-Q · filed 2018-04-16 | |||
| 2017-08-31 | $279.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $431.00 derived: sum of 2 quarters · filed 2018-11-29 | $600.00 10-K · filed 2018-11-29 | |
| 2017-05-31 | $152.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-07-13 | $321.00 10-Q · filed 2018-07-13 | ||
| 2017-02-28 | $169.00 10-Q/A · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |